ATEC · XBRL financial data

Alphatec Holdings financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (ATEC's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cost of revenue43*41434855*53565963*565963
Gross profit—97103103—116129137—136154158
Selling, general and administrative104*114113109115*127119124129*137134133
Total operating expenses140*141138136145*160142153158*159156155
Operating income (loss)(45)*(43)(35)(34)(24)*(44)(13)(16)(9)*(23)(2)3
Interest expense4*5677*8121313*121111
Other income (expense)0*001(2)*010(0)*0(1)(0)
Income tax expense (benefit)(0)*(0)(0)(0)0*(0)(0)0(0)*002
Net income (loss)(49)*(48)(41)(40)(33)*(52)(41)(29)(22)*(34)(26)(5)
Earnings per share, basic USD per share(0.37)*(0.34)(0.29)(0.28)(0.23)*(0.35)(0.27)(0.19)(0.14)*(0.22)(0.16)(0.03)
Earnings per share, diluted USD per share(0.37)*(0.34)(0.29)(0.28)(0.23)*(0.35)(0.27)(0.19)(0.14)*(0.22)(0.16)(0.03)
Weighted average shares, basic millions of shares134*141143143145*147150151152*154157157
Weighted average shares, diluted millions of shares134*141143143145*147150151152*154157157

Balance sheet

CSV

Fiscal quarters (ATEC's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents2211441008113915315715616114011980
Accounts receivable738984788389969797106110111
Inventory137153172183175171170167169186195207
Prepaid and other current assets212020202021212023242530
Total current assets451405377362417435443440451456449427
Property and equipment, net150171181171156147140138135138139140
Right-of-use asset262437373534343331312948
Goodwill737272737172757575747474
Total assets805775769746776785790787791799791797
Accounts payable496073605339473741466262
Current portion of long-term debt2322232656566655
Total current liabilities158169169156153158154221219240238181
Long-term debt511512517526575546552495501508511542
Lease liability, non-current242130292727262524232244
Accumulated deficit(1,119)(1,167)(1,208)(1,248)(1,281)(1,333)(1,374)(1,403)(1,424)(1,458)(1,484)(1,490)
Total stockholders' equity783817(1)(14)(86)241212(5)(12)(2)
Total liabilities and equity805775769746776785790787791799791797
Common shares outstanding (cover page) millions of shares138140140142144146148149151154154155

Cash flows

CSV

Fiscal quarters (ATEC's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)(49)*(48)(41)(40)(33)*(52)(41)(29)(22)*(34)(26)(5)
Stock-based compensation21*1717*17*22*2216*16*19*2418*14*
Depreciation and amortization16*1820*21*20*2019*19*19*1920*20*
Net cash from operating activities(25)*(38)(11)*(5)*11*(5)16*14*21*121*19*
Purchases of property and equipment26*3134*16*2*1010*9*13*1220*13*
Net cash from investing activities(28)*(34)(36)*(20)*(4)*(12)(12)*(14)*(16)*(20)(23)*(22)*
Proceeds from issuing common stock146*———year only———year only———
Net cash from financing activities152*(4)3*7*51*310*(1)*0*(2)(20)*(36)*
Net change in cash98*(77)(44)*(19)*58*144*(1)*5*(21)(21)*(39)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingRunwayQuarter
Alphatec Holdings8022119*155.1M— 10-QSep 30, 2026
Tandem Diabetes Care63255(35)*69.6M13.2 quarters 10-QJun 30, 2026
Artivion77126(1.3)*48.8M61.1 quarters 10-QJun 30, 2026
CONMED4833649*29.8M— 10-QSep 30, 2026
AtriCure16815422*50.9M— 10-QJun 30, 2026
NovoCure9719323116.9M— 10-QSep 30, 2026
Lemaitre Vascular27not reported16*22.9M— 10-QJun 30, 2026
Establishment Labs Holdings7168(17)*29.8M4.3 quarters 10-QJun 30, 2026
Ufp Technologies917416*7.7M— 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.